![](https://www.fedaiisf.it/wp-content/uploads/2015/04/fedaiisf-ARCHIVIO-STORICO-780x450.jpg)
Prefer generic drugs
http://www.asl.milano.it/ITA/Default.aspx?SEZ=10&PAG=283&NOT=1755
Comments by Riccardo Bevilacqua in green to the article "Prefer generic drugs" of the ASL of Milan, published on the website www.asl.milano.it.
Generics are drugs equivalent to the original brand product, marketed with an expired patent, at a lower price (the lower price is obligated by the State which prevents the free market for the first nine months, a period studied ad hoc, to first convince, and then accustom, patients to prefer generics).
They cover most diseases, but are still met with resistance, due to obvious commercial interests (the same business interests behind the Generics Companies).
Many overestimate all the therapeutic novelties, and underestimate the merits of drugs with consolidated efficacy, with a safety that only verification over time can confirm. Instead, the lesson of too many "novelties" sensationally withdrawn from the market after years of enthusiasm must make generics appreciate, (that the possible withdrawal of "novelty" drugs should make patients appreciate generics has no confirmation) which maintain good long-term safety, with less risk of serious and unexpected adverse effects. (The State first certifies the existence of risks of generic adverse effects by providing for the prescription of original drugs for clinical reasons in the recent DL, and these risks increase for excipients other than the original);
Generics with only the name of the active ingredient, without a fancy name, make life easier, because:
you will make less confusion and you will not risk accumulating the same medicines and taking the same medicine several times without knowing it (with the risk of excessive doses, or in case of allergies) (On the other hand, the exact opposite is true. Many GPs have reported that chronic elderly patients, taking the same generic drug several times a day because they come in different packages, believing them to be different drugs, had consequent overdose problems, ie side effects);
ES: for serious liver risks, recent measures limit the use of nimesulide to a maximum of 15 days &nb